Citation: D. Salmonceron, THERAPEUTIC MANAGEMENT OF CYTOMEGALOVIRUS -INFECTION IN HIV-INFECTED PATIENTS - CURATIVE TREATMENT AND PREEMPTIVE THERAPY - STATE-OF-THE-ART, La Presse medicale, 27(4), 1998, pp. 181-188
Authors:
ROBAIN M
CARRE N
SALMONCERON D
DUSSAIX E
MEYER L
Citation: M. Robain et al., PREVALENCE AND INCIDENCE OF CYTOMEGALOVIR US-INFECTION IN HIV-INFECTED SUBJECTS - THE FRENCH SEROCO COHORT, La Presse medicale, 27(20), 1998, pp. 949-953
Authors:
LEMOING V
BISSUEL F
COSTAGLIOLA D
EID Z
CHAPUIS F
MOLINA JM
SALMONCERON D
BRASSEUR P
LEPORT C
Citation: V. Lemoing et al., DECREASED PREVALENCE OF INTESTINAL CRYPTOSPORIDIOSIS IN HIV-INFECTED PATIENTS CONCOMITANT TO THE WIDESPREAD USE OF PROTEASE INHIBITORS, AIDS, 12(11), 1998, pp. 1395-1397
Authors:
LESUEUR A
FILLET AM
BOUSCARY D
GINSBURG C
PALMER P
CHAINE B
SALMONCERON D
DREYFUS F
HURAUX JM
SICARD D
Citation: A. Lesueur et al., ACYCLOVIR-RESISTANT ZOSTER IN AN IMMUNOCO MPROMISED HIV SERONEGATIVE PATIENT, Annales de dermatologie et de venereologie, 125(2), 1998, pp. 127-128
Authors:
ROBAIN M
CARRE N
DUSSAIX E
SALMONCERON D
MEYER L
Citation: M. Robain et al., INCIDENCE AND SEXUAL RISK-FACTORS OF CYTOMEGALOVIRUS SEROCONVERSION IN HIV-INFECTED SUBJECTS, Sexually transmitted diseases, 25(9), 1998, pp. 476-480
Authors:
GERARD L
LEPORT C
FLANDRE P
HOUHOU B
SALMONCERON D
PEPIN JM
MANDET C
BRUNVEZINET F
VILDE JL
Citation: L. Gerard et al., CYTOMEGALOVIRUS (CMV) VIREMIA AND THE CD4(-IMMUNODEFICIENCY-VIRUS() LYMPHOCYTE COUNT AS PREDICTORS OF CMV DISEASE IN PATIENTS INFECTED WITHHUMAN), Clinical infectious diseases, 24(5), 1997, pp. 836-840
Authors:
COEFFIER E
EXCLER JL
KIENY MP
MEIGNIER B
MOSTE C
TARTAGLIA J
PIALOUX G
SALMONCERON D
LECLERC C
Citation: E. Coeffier et al., RESTRICTED SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN HUMANS BY HIVCANDIDATE VACCINES, AIDS research and human retroviruses, 13(17), 1997, pp. 1471-1485
Authors:
GINSBURG G
AARON L
LESUEUR A
SALMONCERON D
SICARD D
Citation: G. Ginsburg et al., GANGLION CRYPTOCCOCOSIS IN AN AIDS PATIEN T ON LONG-TERM FLUCONOZOLE - RELAPSE OR CURE, La Presse medicale, 26(22), 1997, pp. 1049-1049
Authors:
DUVAL X
CLAYETTE P
DEREUDDREBOSQUET N
FRETIER P
MARTIN M
SALMONCERON D
GRAS G
VILDE JL
DORMONT D
Citation: X. Duval et al., DAPSONE AND HIV-1 REPLICATION IN PRIMARY CULTURES OF LYMPHOCYTES AND MONOCYTE-DERIVED MACROPHAGES, AIDS, 11(7), 1997, pp. 943-944
Authors:
GINSBURG C
SALMONCERON D
VASSILIEF D
RABIAN C
ROTSCHILD C
FONTENAYROUPIE M
STIELTJES N
SICARD D
Citation: C. Ginsburg et al., UNUSUAL OCCURRENCE OF SPONTANEOUS HEMATOMAS IN 3 ASYMPTOMATIC HIV-INFECTED HEMOPHILIA PATIENTS A FEW DAYS AFTER THE ONSET OF RITONAVIR TREATMENT, AIDS, 11(3), 1997, pp. 388-389
Authors:
CARRE N
ROBAIN M
DUSSAIX E
SALMONCERON D
MEYER L
ROUZIOUX C
BARY M
BURGARD M
DELLAMONICA P
DURANT J
GALLAIS H
MARS ME
GALLAIS J
DORMONT J
LEVY A
BOUE F
LEFRERE JJ
LERABLE J
JOUBERT L
CASSUTO JP
REBOULOT B
QUARANTA M
DUPONT B
BEUZELIN C
FOURNIER S
VITTECOQ D
BOLLIOT C
PECHALAT MT
HERSON S
COUTELLIER A
GASTAUT JA
DHIVER C
DROGOUL MP
SERENI D
GOMEZ V
BACHMEYER C
VILDE JL
LEPORT C
COLASSANTE U
KATLAMA C
BRUCKER G
SOBEL A
DUVAL J
MAJERHOLC C
DEFORGES L
KAZATCHKINE M
VELLAY A
BUISSON M
DELFRAISSY JF
LEBRAS P
GOUJARD C
QUERTAINMONT Y
GUILLEVIN L
JAROUSSE B
TROGOFF B
Citation: N. Carre et al., SEXUAL FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS SEROPOSITIVITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN, Sexually transmitted diseases, 24(10), 1997, pp. 582-586
Citation: D. Salmonceron, PRIMARY AND SECONDARY CYTOMEGALOVIRUS INF ECTIONS IN THE IMMUNOSUPPRESSED PATIENTS, Annales de medecine interne, 148(3), 1997, pp. 246-254
Citation: Jl. Vilde et D. Salmonceron, IRON OVERLOAD AS A MECHANISM FOR THE LOWERED SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE-IRON PROTOXALATE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA - REPLY, The Journal of infectious diseases, 174(1), 1996, pp. 242-242
Citation: Jl. Vilde et D. Salmonceron, RANDOMIZATION TO IRON SUPPLEMENTATION OF PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - AN INADVERTENT BUT CONTROLLED-STUDY WITH RESULTS IMPORTANT FOR PATIENT-CARE - REPLY, The Journal of infectious diseases, 173(4), 1996, pp. 1045-1045
Citation: L. Gerard et D. Salmonceron, PHARMACOLOGY AND CLINICAL USE OF FOSCARNET, International journal of antimicrobial agents, 5(4), 1995, pp. 209-217
Authors:
SALMONCERON D
EXCLER JL
SICARD D
BLANCHE P
FINKIELSTZJEN L
GLUCKMAN JC
AUTRAN B
MATTHEWS TJ
MEIGNIER B
KIENY MP
VALENTIN C
GONNET P
DIAZ I
SALOMON H
PIALOUX G
GONZALEZCANALI G
PLOTKIN S
Citation: D. Salmonceron et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS, AIDS research and human retroviruses, 11(12), 1995, pp. 1479-1486
Authors:
SALMONCERON D
FONTBONNE A
SABA J
MAY T
RAFFI F
CHIDIAC C
PATEY O
ABOULKER JP
SCHWARTZ D
VILDE JL
Citation: D. Salmonceron et al., LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA, The Journal of infectious diseases, 172(3), 1995, pp. 656-664
Authors:
PERRONNE C
SABA J
BEHLOUL Z
SALMONCERON D
LEPORT C
VILDE JL
KAHN MF
Citation: C. Perronne et al., PYOGENIC AND TUBERCULOUS SPONDYLODISKITIS (VERTEBRAL OSTEOMYELITIS) IN 80 ADULT PATIENTS, Clinical infectious diseases, 19(4), 1994, pp. 746-750
Authors:
LORTHOLARY O
MEYOHAS MC
DUPONT B
CADRANEL J
SALMONCERON D
PEYRAMOND D
SIMONIN D
FROTTIER J
GILQUIN J
ARMENGAUD M
CHOUAID C
DELZANT G
DETRUCHIS P
DOURNAN E
Citation: O. Lortholary et al., INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME - REPORT OF 33 CASES, The American journal of medicine, 95(2), 1993, pp. 177-187